China’s Ascendancy in Global Clinical Trials: Inside the 2026 OCT and CTS China Conference
Executive Overview The global clinical trials landscape is undergoing a structural realignment, with the People’s Republic of China firmly anchoring itself at the epicenter of this transformation. Once regarded primarily…